China is one of the world’s key growth markets and an equally promising future has been forecast for the Russian pharma market. Gerresheimer recognised this development early on and believes it is important to be present as a direct local contact in these markets. Gerresheimer operates seven production plants in China alone and has built up an extensive distribution network. In Russia, the first Gerresheimer representative office was opened this year.
Now the Gerresheimer website has been supplemented with Chinese and Russian versions.
“We want to be closer to our customers and serve local growth markets in the local language,” said Jens Kürten, Director Corporate Communication and Marketing.
Condensed versions of the website were localised in the Chinese and Russian languages to enhance customer service and accessibility. The aim is to present the relevant products in the portfolio to website users with the minimum number of clicks and to give existing and potential customers fast access to local contacts.
The Chinese and Russian web pages can be accessed directly via the language selection buttons, or gerresheimer.cn and gerresheimer.ru.
The user initially sees an overview page containing information about the Gerresheimer Group and brief descriptions of the individual divisions consisting of informative images and short texts. The sub-pages feature brief descriptions of individual products or product groups and services. All the relevant contacts are displayed directly underneath. The web pages are rounded off with a map showing local sites, plus photo and contact details.
Gerresheimer is a leading manufacturer of high quality specialty glass and plastic products for the international pharmaceuticals and healthcare industries. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group has production operations at 40 sites in Europe, North and South America and Asia. It realizes sales of around one billion euros and has 9,500 employees. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.
Director Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
E-Mail: please click